Diabetes MellitusFAITH-DMNCT02569060
Feeding America Intervention Trial for Health--Diabetes Mellitus
A study testing Testing and Monitoring of Blood Glucose Levels, Primary care coordination and Diabetes-appropriate food packages in people with Diabetes Mellitus, run by University of California, San Francisco at 4 sites in United States.
Trial summary
The Feeding America Intervention Trial for Health-Diabetes Mellitus (FAITH-DM) is a randomized, controlled study of the implementation of a diabetes intervention in food pantry settings. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Diabetes Mellitus
- What is being tested?
- Testing and Monitoring of Blood Glucose Levels, Primary care coordination and Diabetes-appropriate food packages
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 568 participants
- Where
- 4 sitesUnited States
- Study dates
- Oct 2015to 31 Oct 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Food pantry client at one of three participating food banks: Alameda County Community Food Bank (Oakland, CA), Gleaners Community Food Bank of Southeastern Michigan (Detroit, MI), Houston Food Bank, (Houston, TX)
- Type II diabetes mellitus with HbA1c ≥ 7.5% using food bank point-of-care testing
- Reliable mode of contact (either phone or address)
- English or Spanish verbal fluency
- 18 years of age or older
- Intent to remain in the study area for at least the next 12 months
- Willingness to participate in intervention
Who cannot join
- Type 1 diabetes
- Pregnant or less than 6 weeks post-partum
- Cognitively impaired: dementia, mental illness, or active substance abuse severe enough to interfere with administration of the survey or participation in the intervention
- Household member already enrolled in the study
Trial locations and contacts
4 sites in 1 country.
United States4 sites
Gleaners Community Food Bank of Southeastern Michigan
Detroit, Michigan, 48207
Houston Food Bank
Houston, Texas, 77029
Alameda County Community Food Bank
Oakland, California, 94614
University of California San Francisco
San Francisco, California, 94143
About this study
The Feeding America Intervention Trial for Health-Diabetes Mellitus (FAITH-DM) is a randomized, controlled study of the implementation of a diabetes intervention in food pantry settings.
Read the detailed description
For adults with diabetes mellitus, diabetes self-management education (DSME) is critical to achieving long-term control of blood sugar levels (glycemic control) and preventing diabetes-associated complications. This education is often difficult to access for highly vulnerable and marginalized adults in the United States. Furthermore, foods for a diabetic diet are often out of reach for food insecure households. The purpose of this study is to determine the extent to which food banks and food pantries can help reach this population with effective DSME, food, and access to primary health care. The investigators' primary outcome of interest is HbA1c improvement in the intervention group compared to a wait-listed control group of food pantry clients living with uncontrolled type 2 diabetes.
- Conditions
- Diabetes Mellitus
- Being tested
- Testing and Monitoring of Blood Glucose Levels, Primary care coordination, Diabetes-appropriate food packages, Diabetes self-management education
- Keywords
- diabetes mellitus, community intervention, intervention, randomized, dietary intervention, self-management support, food bank
- Medical subject headings
- Diabetes Mellitus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Testing and Monitoring of Blood Glucose LevelsOther
Point-of-care testing of HbA1c levels at the food pantry at approximately 3 month intervals
Primary care coordinationOther
Referral to a local primary care provider, if none currently exists. Coordination of care with primary care provider.
Diabetes-appropriate food packagesOther
Food (perishable and non-perishable) appropriate for diabetes self-management available for pick-up at the food pantry twice monthly.
Diabetes self-management educationBehavioural
Education materials drawn from evidence-based practice and adapted from existing diabetes education curricula to be flexible to individual, community, and site variations. The Immediate Intervention Arm receives more robust diabetes self-management education (with group education visits) than the Waitlist Control Arm.
| Study group | Role | What they receive |
|---|---|---|
| Immediate Intervention | Experimental | Participants randomized to the Intervention Arm will immediately begin a four-component intervention.
1. Testing and monitoring of blood glucose levels
2. Referral to and/or coordination with primary care provider
3. Diabetes-appropriate food packages
4. Diabetes self-management education and support Receives: Other: Testing and Monitoring of Blood Glucose Levels; Other: Primary care coordination; Other: Diabetes-appropriate food packages; Behavioral: Diabetes self-management education |
| Waitlist Control | Active comparator | Participants randomized to the Waitlist Control arm will receive no intervention for six months, after which time they will begin a modified, four-component intervention.
1. Testing and monitoring of blood glucose levels
2. Referral to and/or coordination with primary care provider
3. Diabetes-appropriate food packages
4. Limited diabetes self-management education and support Receives: Other: Testing and Monitoring of Blood Glucose Levels; Other: Primary care coordination; Other: Diabetes-appropriate food packages; Behavioral: Diabetes self-management education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from Baseline HbA1c at 6 Months
Point-of-care HbA1c testing with the PTS Diagnostics A1CNow®+ System
Measured: 6 months
Secondary outcomes (9)
Change from Baseline Dietary Intake
Brief fruit \& vegetable dietary screener
Measured: 6 months and 12 months
Change from Baseline Health Care Utilization
Communication with primary care provider requesting dates of service, service levels, and diagnosis codes
Measured: 6 months and 12 months
Change from Baseline Diabetes Distress
Self-reported distress as assessed by the 2-item emotional burden sub-score of the Diabetes Distress Scale
Measured: 6 months and 12 months
Change from Baseline Hypoglycemic events
Self-reported hypoglycemic events over the previous 4 weeks, both any events and number of events, and self-reported severe hypoglycemic episodes, both any events and number of events
Measured: 6 months and 12 months
Change from Baseline Depressive symptoms
PHQ-8 (a subset of PHQ-9 scores without assessment of suicidality)
Measured: 6 months and 12 months
Change from Baseline Medication Adherence
Morisky Medication Adherence Scale (4 items)
Measured: 6 months and 12 months
Food vs medicine trade-offs
Three self-reported questions
Measured: 6 months and 12 months
Change from Baseline Food security status
6-item version of the USDA's Core Food Security Survey Module
Measured: 6 months and 12 months
Change from Baseline Food stability
Two items assessing adequacy of food resources to last the entire month
Measured: 6 months and 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Oct 2015 (estimated)
- Study startOct 2015
- Primary completion31 Oct 2017
- Study completion31 Oct 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Diabetes MellitusStudies of the same condition, open and under way.
- More trials run by University of California, San FranciscoThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 568 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of California, San Francisco
- Sponsor type
- University, hospital or other
- Collaborators
- Feeding America, Laura and John Arnold Foundation, Urban Institute
- Responsible party
- Sponsor
- Investigators
- Hilary K Seligman, MD MAS, Principal investigator, University of California, San Francisco
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02569060
- Sponsor's protocol ID
- A125548
- Acronym
- FAITH-DM
- Status last verified
- May 2020
- First submitted
- 2 Oct 2015
- Last updated
- 18 May 2020
- Results posted
- No
- Data monitoring committee
- No
Publications
Seligman HK, Levi R, Ridberg R, Smith M, Hills N, Waxman E. Impact of Enhanced Food Pantry Services on Food Security among Adults with Diabetes Using a Crossover Study Design. Curr Dev Nutr. 2022 Feb 10;6(4):nzac021. doi: 10.1093/cdn/nzac021. eCollection 2022 Apr.
PubMed 35415385Smith M, Rosenmoss S, Seligman HK. Point-of-Care Hemoglobin A1C Testing System in Community Settings: Challenges, Opportunities, and Measurement Characteristics. Prog Community Health Partnersh. 2020;14(3):327-335. doi: 10.1353/cpr.2020.0038.
PubMed 33416608Seligman HK, Smith M, Rosenmoss S, Marshall MB, Waxman E. Comprehensive Diabetes Self-Management Support From Food Banks: A Randomized Controlled Trial. Am J Public Health. 2018 Sep;108(9):1227-1234. doi: 10.2105/AJPH.2018.304528. Epub 2018 Jul 19.
PubMed 30024798
Study at a glance
From the registry record, last updated by the sponsor on 18 May 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feeding America Intervention Trial for Health--Diabetes Mellitus
- ClinicalTrials.gov ID
- NCT02569060
- Acronym / sponsor ID
- FAITH-DM / A125548
- Conditions
- Diabetes Mellitus
- Keywords
- diabetes mellitus, community intervention, intervention, randomized, dietary intervention, self-management support, food bank
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 568 participants (actual)
- Lead sponsor
- University of California, San FranciscoUniversity, hospital or other
- Collaborators
- Feeding America, Laura and John Arnold Foundation, Urban Institute
- Study start
- Oct 2015 (actual)
- Primary completion
- 31 Oct 2017 (actual)
- Study completion
- 31 Oct 2017 (actual)
- First posted
- 6 Oct 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Feeding America Intervention Trial for Health-Diabetes Mellitus (FAITH-DM) is a randomized, controlled study of the implementation of a diabetes intervention in food pantry settings.
Detailed description
For adults with diabetes mellitus, diabetes self-management education (DSME) is critical to achieving long-term control of blood sugar levels (glycemic control) and preventing diabetes-associated complications. This education is often difficult to access for highly vulnerable and marginalized adults in the United States. Furthermore, foods for a diabetic diet are often out of reach for food insecure households. The purpose of this study is to determine the extent to which food banks and food pantries can help reach this population with effective DSME, food, and access to primary health care. The investigators' primary outcome of interest is HbA1c improvement in the intervention group compared to a wait-listed control group of food pantry clients living with uncontrolled type 2 diabetes.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Immediate Intervention | Experimental | Other: Testing and Monitoring of Blood Glucose Levels, Other: Primary care coordination, Other: Diabetes-appropriate food packages, Behavioral: Diabetes self-management educationParticipants randomized to the Intervention Arm will immediately begin a four-component intervention. 1. Testing and monitoring of blood glucose levels 2. Referral to and/or coordination with primary care provider 3. Diabetes-appropriate food packages 4. Diabetes self-management education and support |
| Waitlist Control | Active comparator | Other: Testing and Monitoring of Blood Glucose Levels, Other: Primary care coordination, Other: Diabetes-appropriate food packages, Behavioral: Diabetes self-management educationParticipants randomized to the Waitlist Control arm will receive no intervention for six months, after which time they will begin a modified, four-component intervention. 1. Testing and monitoring of blood glucose levels 2. Referral to and/or coordination with primary care provider 3. Diabetes-appropriate food packages 4. Limited diabetes self-management education and support |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Food pantry client at one of three participating food banks: Alameda County Community Food Bank (Oakland, CA), Gleaners Community Food Bank of Southeastern Michigan (Detroit, MI), Houston Food Bank, (Houston, TX)
- Type II diabetes mellitus with HbA1c ≥ 7.5% using food bank point-of-care testing
- Reliable mode of contact (either phone or address)
- English or Spanish verbal fluency
- 18 years of age or older
Key exclusion criteria (4 listed)
- Type 1 diabetes
- Pregnant or less than 6 weeks post-partum
- Cognitively impaired: dementia, mental illness, or active substance abuse severe enough to interfere with administration of the survey or participation in the intervention
- Household member already enrolled in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Testing and Monitoring of Blood Glucose LevelsPoint-of-care testing of HbA1c levels at the food pantry at approximately 3 month intervals | Other | Immediate Intervention, Waitlist Control |
| Primary care coordinationReferral to a local primary care provider, if none currently exists. Coordination of care with primary care provider. | Other | Immediate Intervention, Waitlist Control |
| Diabetes-appropriate food packagesFood (perishable and non-perishable) appropriate for diabetes self-management available for pick-up at the food pantry twice monthly. | Other | Immediate Intervention, Waitlist Control |
| Diabetes self-management educationEducation materials drawn from evidence-based practice and adapted from existing diabetes education curricula to be flexible to individual, community, and site variations. The Immediate Intervention Arm receives more robust diabetes self-management education (with group education visits) than the Waitlist Control Arm. | Behavioural | Immediate Intervention, Waitlist Control |
Primary outcome
Change from Baseline HbA1c at 6 Months
Time frame: 6 months
Point-of-care HbA1c testing with the PTS Diagnostics A1CNow®+ System
9 secondary outcomes
Change from Baseline Dietary Intake
Time frame: 6 months and 12 months
Change from Baseline Health Care Utilization
Time frame: 6 months and 12 months
Change from Baseline Diabetes Distress
Time frame: 6 months and 12 months
Change from Baseline Hypoglycemic events
Time frame: 6 months and 12 months
Change from Baseline Depressive symptoms
Time frame: 6 months and 12 months
Change from Baseline Medication Adherence
Time frame: 6 months and 12 months
Food vs medicine trade-offs
Time frame: 6 months and 12 months
Change from Baseline Food security status
Time frame: 6 months and 12 months
Change from Baseline Food stability
Time frame: 6 months and 12 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 May 2020.
- Derived from this study: PubMed 35415385Seligman HK, Levi R, Ridberg R, Smith M, Hills N, Waxman E. Impact of Enhanced Food Pantry Services on Food Security among Adults with Diabetes Using a Crossover Study Design. Curr Dev Nutr. 2022 Feb 10;6(4):nzac021. doi: 10.1093/cdn/nzac021. eCollection 2022 Apr.
- Derived from this study: PubMed 33416608Smith M, Rosenmoss S, Seligman HK. Point-of-Care Hemoglobin A1C Testing System in Community Settings: Challenges, Opportunities, and Measurement Characteristics. Prog Community Health Partnersh. 2020;14(3):327-335. doi: 10.1353/cpr.2020.0038.
- Derived from this study: PubMed 30024798Seligman HK, Smith M, Rosenmoss S, Marshall MB, Waxman E. Comprehensive Diabetes Self-Management Support From Food Banks: A Randomized Controlled Trial. Am J Public Health. 2018 Sep;108(9):1227-1234. doi: 10.2105/AJPH.2018.304528. Epub 2018 Jul 19.
Related trials for Diabetes Mellitus
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults
Hyperglycaemia (Non Diabetic), Prediabetes
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hilary K Seligman, MD MAS principal investigator
University of California, San Francisco
4 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Testing and Monitoring of Blood Glucose Levels, Primary care coordination and Diabetes-appropriate food packages in people with Diabetes Mellitus, run by University of California, San Francisco at 4 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 May 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from Baseline HbA1c at 6 Months (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02569060, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2020.